Skip to main content
. 2025 Jan 3;15:730. doi: 10.1038/s41598-024-83144-6

Table 4.

Growth curve modeling results of PTSD symptoms (PCL-5), b (95% confidence interval).

Model 1 Model 2
Intercept

25.20 (22.99, 27.41)

t = 22.34***

22.29 (19.90, 24.68)

t = 18.31***

Baseline PCL-5 ≥ 31 (Ref: PCL < 31)

21.76 (19.09, 24.42)

t = 16.00***

26.82 (23.67, 29.96)

t = 16.73***

Week

− 2.53 (− 3.09, − 1.98)

t = − 8.95***

− 0.81 (− 1.61, − 0.01)

t = − 1.99*

Week2

0.06 (0.03, 0.10)

t = 3.82***

− 0.01 (− 0.06, 0.04)

t = − 0.51

Week * Baseline PCL-5 ≥ 31

− 2.99 (− 4.04, − 1.95)

t = − 5.64***

Week2 * Baseline PCL-5 ≥ 31

0.14 (0.07, 0.20)

t = 4.11***

Deviance (− 2*Log likelihood) 10,443.05 10,406.47
Akaike inf. crit 10,465.05 10,432.47
Bayesian inf. crit 10,523.04 10,501.01

PCL-5: PTSD Checklist for DSM-5. Baseline PCL-5 indicator is coded: 0 = PCL-5 < 31, 1 = PCL-5 ≥ 31. Model 1 residual degrees of freedom = 1428, and Model 2 residual degrees of freedom = 1426. Likelihood ratio test: Inline graphic(2) = 36.57, p < 0.001.

*p < 0.05; **p < 0.01; ***p < 0.001.